by Strados Labs | Apr 8, 2024 | Events
Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18. Hosted by the American Thoracic Society, the Respiratory Innovation Summit...
by Strados Labs | Feb 27, 2024 | Blog, Blog - Clinical Trial Focus
24-hour cough frequency has traditionally been recognized as the ‘gold standard’ primary endpoint for indications such as refractory chronic cough, chronic bronchitis, and IPF-related cough. While frequency is undoubtedly a valuable metric to measure for cough, there...
by Strados Labs | Jan 29, 2024 | Blog, Blog - Clinical Trial Focus
In December 2023, the FDA published its final release of “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations” a pivotal step in formalizing regulatory standards and guidance for remote data collection in clinical trials. As the...
by Strados Labs | Dec 12, 2023 | Press Releases
We are thrilled to announce that through our various partnerships with life sciences organizations, Strados Labs has successfully captured a staggering 10 million breaths in this year alone - and counting! This milestone marks a significant step towards advancing...
by Strados Labs | Sep 26, 2023 | Press Releases
Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial at Lurie Children’s to determine if the technology can accurately detect wheezing and other symptoms of asthma exacerbation in children. PHILADELPHIA, PA – September 26th, 2023 – Strados...
